Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study (Q58204653)

1

0 references

M. Montejo

2

0 references

L. Castells

3

0 references

A. Rafecas

4

0 references

S. Moreno

5

0 references

F. Agüero

6

0 references

M. Abradelo

7

0 references

P. Miralles

8

0 references

J. Torre-Cisneros

9

0 references

J. D. Pedreira

10

0 references

G. de la Rosa

12

0 references

B. Moyano

13

0 references

A. Moreno

14

0 references

I. Perez

15

0 references

A. Rimola

American Journal of Transplantation

16

0 references

language of work or name

English

0 references

publication date

4 April 2012

0 references

published in

0 references

volume

12

0 references

issue

7

0 references

page(s)

1866-1876

0 references

cites work

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Liver transplantation in a patient infected by human immunodefficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Characteristics associated with liver graft failure: the concept of a donor risk index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH en el año 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Evolution of hepatitis C virus in liver allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Risk factors for hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Outcomes after orthotopic liver transplantation in 15 HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

The effect of the volume of procedures at transplantation centers on mortality after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

Relationship between provider volume and outcomes for orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04028.X